Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Periodicals
Pfizer sees return to normal by end of 2022, CEO tells CNBC » 11:54
06/16/21
06/16
11:54
06/16/21
11:54
PFE

Pfizer

$39.69 /

+0.09 (+0.23%)

, BNTX

BioNTech

$202.25 /

-15.73 (-7.22%)

Pfizer (PFE) CEO Albert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$39.69 /

+0.09 (+0.23%)

BNTX BioNTech
$202.25 /

-15.73 (-7.22%)

PFE Pfizer
$39.69 /

+0.09 (+0.23%)

06/07/21 BofA
BofA upgrades Biogen to Neutral with $400 price target after Aduhelm approved
06/01/21 Argus
Argus says market underestimating sustainability of Pfizer COVID vaccine program
05/18/21 William Blair
William Blair says continued lack of '9001 safety signals positive for Sarepta
05/12/21 Canaccord
BioNTech price target raised to $240 from $130 at Canaccord
BNTX BioNTech
$202.25 /

-15.73 (-7.22%)

09:53 Today
Fly Intel: Top five analyst downgrades
05:05 Today Redburn
BioNTech downgraded to Sell from Neutral at Redburn
05/18/21
Fly Intel: Top five analyst initiations
05/18/21 Goldman Sachs
BioNTech initiated with a Neutral at Goldman Sachs
PFE Pfizer
$39.69 /

+0.09 (+0.23%)

BNTX BioNTech
$202.25 /

-15.73 (-7.22%)

  • 23
    Jul
PFE Pfizer
$39.69 /

+0.09 (+0.23%)

BNTX BioNTech
$202.25 /

-15.73 (-7.22%)

PFE Pfizer
$39.69 /

+0.09 (+0.23%)

BNTX BioNTech
$202.25 /

-15.73 (-7.22%)

PFE Pfizer
$39.69 /

+0.09 (+0.23%)

BNTX BioNTech
$202.25 /

-15.73 (-7.22%)

Hot Stocks
Novocure initiates usability study for flexible torso array » 07:32
06/16/21
06/16
07:32
06/16/21
07:32
NVCR

Novocure

$216.59 /

-3.1 (-1.41%)

Novocure announced it has…

Novocure announced it has advanced a new, flexible torso array into a clinical usability study. The updated array will be tested by patients and their caregivers at four clinical sites in Europe. Novocure designed the array to improve patient comfort for all torso and abdominal indications. The new design is intended to improve skin adhesion, to increase degrees-of-motion, and potentially to reduce skin irritation. Novocure plans to conclude the usability study in the third quarter of 2021 and will identify the preferred regulatory pathway to bring the updated, flexible array to patients as soon as possible.

ShowHide Related Items >><<
NVCR Novocure
$216.59 /

-3.1 (-1.41%)

NVCR Novocure
$216.59 /

-3.1 (-1.41%)

04/19/21 Truist
Novocure price target raised to $142 from $132 at Truist
04/14/21
Fly Intel: Top five analyst downgrades
04/14/21 Northland
Novocure price target raised to $250 from $200 at Northland
04/14/21 Wedbush
Novocure downgraded to Underperform at Wedbush after LUNAR update
NVCR Novocure
$216.59 /

-3.1 (-1.41%)

NVCR Novocure
$216.59 /

-3.1 (-1.41%)

Hot Stocks
Zhongchao, AbbVie announce cooperation n physician education » 06:41
06/16/21
06/16
06:41
06/16/21
06:41
ZCMD

Zhongchao

$1.76 /

-0.03 (-1.68%)

, ABBV

AbbVie

$115.82 /

+0.47 (+0.41%)

Zhongchao (ZCMD)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZCMD Zhongchao
$1.76 /

-0.03 (-1.68%)

ABBV AbbVie
$115.82 /

+0.47 (+0.41%)

ZCMD Zhongchao
$1.76 /

-0.03 (-1.68%)

ABBV AbbVie
$115.82 /

+0.47 (+0.41%)

05/19/21 Piper Sandler
Piper 'incrementally bullish' on Biohaven, AbbVie migraine drugs
05/13/21 Cantor Fitzgerald
Soliton downgraded to Neutral from Overweight at Cantor Fitzgerald
05/11/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
05/03/21 Mizuho
AbbVie price target raised to $128 from $126 at Mizuho
ABBV AbbVie
$115.82 /

+0.47 (+0.41%)

ABBV AbbVie
$115.82 /

+0.47 (+0.41%)

ABBV AbbVie
$115.82 /

+0.47 (+0.41%)

ABBV AbbVie
$115.82 /

+0.47 (+0.41%)

Conference/Events
European Hematology Association to hold virtual meeting » 04:55
06/16/21
06/16
04:55
06/16/21
04:55
APTO

Aptose Biosciences

$3.50 /

-0.21 (-5.66%)

, MBIO

Mustang Bio

$3.57 /

-0.115 (-3.13%)

, QURE

uniQure

$34.46 /

-0.43 (-1.23%)

, RIGL

Rigel Pharmaceuticals

$4.27 /

-0.1 (-2.29%)

, MGTA

Magenta Therapeutics

$11.38 /

+0.05 (+0.44%)

, MEIP

MEI Pharma

$3.10 /

-0.15 (-4.62%)

, CRIS

Curis

$7.61 /

-0.44 (-5.47%)

, XLRN

Acceleron

$128.63 /

-2.39 (-1.82%)

, EPZM

Epizyme

$8.79 /

-0.025 (-0.28%)

, INCY

Incyte

$82.69 /

+0.11 (+0.13%)

, ORTX

Orchard Therapeutics

$4.85 /

-0.19 (-3.77%)

, TGTX

TG Therapeutics

$37.42 /

-0.88 (-2.30%)

, EQ

Equillium

$6.05 /

+0.05 (+0.83%)

, JAZZ

Jazz Pharmaceuticals

$183.42 /

-2.7 (-1.45%)

, VRTX

Vertex Pharmaceuticals

$188.94 /

-5.87 (-3.01%)

, SGEN

Seagen

$153.20 /

-2.99 (-1.91%)

, IMRA

Imara

$8.26 /

-0.44 (-5.06%)

, GBT

Global Blood Therapeutics

$39.60 /

-0.65 (-1.61%)

, BGNE

BeiGene

$332.97 /

-9.75 (-2.84%)

, APLS

Apellis

$60.63 /

-4.27 (-6.58%)

, AGIO

Agios Pharmaceuticals

$58.23 /

+0.04 (+0.07%)

, FMTX

Forma Therapeutics

$24.13 /

-0.09 (-0.37%)

, KROS

Keros Therapeutics

$52.55 /

-0.455 (-0.86%)

, CYAD

Celyad

$5.44 /

+0.03 (+0.55%)

, ALXN

Alexion

$181.90 /

+0.25 (+0.14%)

EHA 2021 Virtual Congress…

EHA 2021 Virtual Congress to be held on June 9-17. Webcast Link

ShowHide Related Items >><<
XLRN Acceleron
$128.63 /

-2.39 (-1.82%)

VRTX Vertex Pharmaceuticals
$188.94 /

-5.87 (-3.01%)

TGTX TG Therapeutics
$37.42 /

-0.88 (-2.30%)

SGEN Seagen
$153.20 /

-2.99 (-1.91%)

RIGL Rigel Pharmaceuticals
$4.27 /

-0.1 (-2.29%)

QURE uniQure
$34.46 /

-0.43 (-1.23%)

ORTX Orchard Therapeutics
$4.85 /

-0.19 (-3.77%)

MGTA Magenta Therapeutics
$11.38 /

+0.05 (+0.44%)

MEIP MEI Pharma
$3.10 /

-0.15 (-4.62%)

MBIO Mustang Bio
$3.57 /

-0.115 (-3.13%)

KROS Keros Therapeutics
$52.55 /

-0.455 (-0.86%)

JAZZ Jazz Pharmaceuticals
$183.42 /

-2.7 (-1.45%)

INCY Incyte
$82.69 /

+0.11 (+0.13%)

IMRA Imara
$8.26 /

-0.44 (-5.06%)

GBT Global Blood Therapeutics
$39.60 /

-0.65 (-1.61%)

FMTX Forma Therapeutics
$24.13 /

-0.09 (-0.37%)

EQ Equillium
$6.05 /

+0.05 (+0.83%)

EPZM Epizyme
$8.79 /

-0.025 (-0.28%)

CYAD Celyad
$5.44 /

+0.03 (+0.55%)

CRIS Curis
$7.61 /

-0.44 (-5.47%)

BGNE BeiGene
$332.97 /

-9.75 (-2.84%)

APTO Aptose Biosciences
$3.50 /

-0.21 (-5.66%)

APLS Apellis
$60.63 /

-4.27 (-6.58%)

ALXN Alexion
$181.90 /

+0.25 (+0.14%)

AGIO Agios Pharmaceuticals
$58.23 /

+0.04 (+0.07%)

APTO Aptose Biosciences
$3.50 /

-0.21 (-5.66%)

02/22/21 JonesTrading
Aptose Biosciences resumed with a Buy at JonesTrading
10/19/20 Cantor Fitzgerald
Aptose Biosciences initiated with an Overweight at Cantor Fitzgerald
09/22/20 Alliance Global Partners
Aptose Biosciences initiated with a Buy at Alliance Global Partners
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
MBIO Mustang Bio
$3.57 /

-0.115 (-3.13%)

05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/17/21 BTIG
Mustang Bio initiated with a Buy at BTIG
05/12/21 Cantor Fitzgerald
Mustang Bio EHA abstract data 'looks promising,' says Cantor Fitzgerald
12/23/20 B. Riley
Mustang Bio transferred with a Buy at B. Riley Securities
QURE uniQure
$34.46 /

-0.43 (-1.23%)

06/14/21 BTIG
uniQure initiated with a Buy at BTIG
05/20/21 UBS
uniQure initiated with a Neutral at UBS
05/19/21 H.C. Wainwright
uniQure price target raised to $90 from $80 at H.C. Wainwright
04/26/21 Chardan
Chardan sees 'stock momentum' for uniQure after clinical hold lift
RIGL Rigel Pharmaceuticals
$4.27 /

-0.1 (-2.29%)

06/11/21 BMO Capital
Rigel Pharmaceuticals coverage transferred at BMO Capital
05/12/21 Cantor Fitzgerald
Rigel rallying on Curis IRAK4 program data, says Cantor Fitzgerald
04/13/21 Piper Sandler
Rigel results in severe COVID-19 trial 'pretty dramatic,' says Piper Sandler
02/18/21 H.C. Wainwright
Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright
MGTA Magenta Therapeutics
$11.38 /

+0.05 (+0.44%)

06/14/21 BTIG
Magenta Therapeutics initiated with a Buy at BTIG
05/18/21 B. Riley
Magenta Therapeutics initiated with a Buy, $21 target at B. Riley
05/17/21 B. Riley
Magenta Therapeutics initiated with a Buy at B. Riley
05/13/21 Mizuho
Magenta Therapeutics price target raised to $17 from $16 at Mizuho
MEIP MEI Pharma
$3.10 /

-0.15 (-4.62%)

04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
10/12/20 Brookline
MEI Pharma initiated with a Buy at Brookline
09/22/20 Alliance Global Partners
MEI Pharma initiated with a Buy at Alliance Global Partners
07/06/20 Truist
MEI Pharma price target lowered to $12 from $16 at SunTrust
CRIS Curis
$7.61 /

-0.44 (-5.47%)

05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
05/13/21 Cantor Fitzgerald
Curis price target raised to $24 from $15 at Cantor Fitzgerald
05/12/21 Cantor Fitzgerald
Initial look from Curis EHA updates 'very positive,' says Cantor Fitzgerald
XLRN Acceleron
$128.63 /

-2.39 (-1.82%)

06/11/21 H.C. Wainwright
Acceleron results for Phase 2 BEYOND study 'impressive,' says H.C. Wainwright
05/19/21 Piper Sandler
Piper remains bullish on Acceleron after Phase 2 PULSAR OLE, SPECTRA updates
04/26/21 Credit Suisse
Acceleron assumed with an Outperform at Credit Suisse
03/23/21
Fly Intel: Top five analyst downgrades
EPZM Epizyme
$8.79 /

-0.025 (-0.28%)

05/07/21 SVB Leerink
Epizyme upgraded to Outperform from Market Perform at SVB Leerink
04/23/21 Cowen
Epizyme transferred with Outperform at Cowen
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
03/30/21 Credit Suisse
Epizyme initiated with an Outperform at Credit Suisse
INCY Incyte
$82.69 /

+0.11 (+0.13%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
ORTX Orchard Therapeutics
$4.85 /

-0.19 (-3.77%)

03/10/21 Stifel
Stifel says Bluebird update on AML provides 'some relief' to other LV players
03/02/21 JPMorgan
Orchard Therapeutics assumed with an Overweight at JPMorgan
03/01/21 Stifel
Orchard Therapeutics initiated with a Buy at Stifel
02/18/21 Goldman Sachs
Orchard selloff on Bluebird Bio news overdone, says Goldman Sachs
TGTX TG Therapeutics
$37.42 /

-0.88 (-2.30%)

04/20/21
Fly Intel: Top five analyst initiations
04/20/21 Goldman Sachs
TG Therapeutics initiated with a Neutral at Goldman Sachs
04/19/21 Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
04/19/21 H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
EQ Equillium
$6.05 /

+0.05 (+0.83%)

03/03/21
Fly Intel: Top five analyst initiations
03/03/21 JonesTrading
Equillium initiated with a Buy at JonesTrading
11/30/20 H.C. Wainwright
Equillium price target lowered to $12 from $22 at H.C. Wainwright
07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
JAZZ Jazz Pharmaceuticals
$183.42 /

-2.7 (-1.45%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
VRTX Vertex Pharmaceuticals
$188.94 /

-5.87 (-3.01%)

06/14/21 Truist
Vertex Pharmaceuticals price target raised to $331 from $305 at Truist
06/14/21 SVB Leerink
Vertex Pharmaceuticals price target lowered to $200 from $250 at SVB Leerink
06/14/21 Deutsche Bank
Grifols upgraded to Buy from Hold at Deutsche Bank
06/13/21 Piper Sandler
Vertex Pharmaceuticals price target lowered to $261 from $347 at Piper Sandler
SGEN Seagen
$153.20 /

-2.99 (-1.91%)

05/17/21 Evercore ISI
Seagen initiated with an In Line at Evercore ISI
04/30/21 Piper Sandler
Seagen price target lowered to $160 from $170 at Piper Sandler
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/30/21 Credit Suisse
Seagen initiated with a Neutral at Credit Suisse
IMRA Imara
$8.26 /

-0.44 (-5.06%)

03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
GBT Global Blood Therapeutics
$39.60 /

-0.65 (-1.61%)

05/07/21 Cantor Fitzgerald
Global Blood Therapeutics price target lowered to $110 from $120 at Cantor Fitzgerald
05/06/21 Piper Sandler
Global Blood price target lowered to $45 from $50 at Piper Sandler
04/14/21
Fly Intel: Top five analyst initiations
04/14/21 SVB Leerink
SVB Leerink bullish on Global Blood Therapeutics, initiates with an Outperform
BGNE BeiGene
$332.97 /

-9.75 (-2.84%)

06/14/21 SVB Leerink
BeiGene price target raised to $417 from $388 at SVB Leerink
03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
APLS Apellis
$60.63 /

-4.27 (-6.58%)

05/20/21 UBS
Apellis initiated with a Buy at UBS
05/18/21 BMO Capital
Apellis price target raised to $68 from $64 at BMO Capital
05/17/21 Oppenheimer
Apellis price target raised to $67 from $64 at Oppenheimer
05/17/21 Raymond James
Apellis price target raised to $115 from $104 at Raymond James
AGIO Agios Pharmaceuticals
$58.23 /

+0.04 (+0.07%)

06/10/21 H.C. Wainwright
Agios Pharmaceuticals initiated with a Buy at H.C. Wainwright
04/30/21 Goldman Sachs
Agios Pharmaceuticals reinstated with a Neutral at Goldman Sachs
04/30/21 Barclays
Agios Pharmaceuticals price target raised to $70 from $65 at Barclays
03/30/21 Piper Sandler
Agios should rally on Forma Therapeutics data, says Piper Sandler
FMTX Forma Therapeutics
$24.13 /

-0.09 (-0.37%)

03/31/21 H.C. Wainwright
Forma Therapeutics price target raised to $55 from $53 at H.C. Wainwright
02/17/21
Fly Intel: Top five analyst initiations
02/17/21 Oppenheimer
Forma Therapeutics initiated with an Outperform at Oppenheimer
KROS Keros Therapeutics
$52.55 /

-0.455 (-0.86%)

12/08/20 SVB Leerink
Keros Therapeutics price target raised to $80 from $42 at SVB Leerink
12/08/20 H.C. Wainwright
Keros Therapeutics price target raised to $100 from $50 at H.C. Wainwright
12/08/20 Piper Sandler
Keros Therapeutics price target raised to $95 from $75 at Piper Sandler
11/18/20 Piper Sandler
Keros Therapeutics price target raised to $75 from $55 at Piper Sandler
CYAD Celyad
$5.44 /

+0.03 (+0.55%)

03/25/21 JonesTrading
Celyad downgraded to Hold from Buy at JonesTrading
12/08/20 H.C. Wainwright
Celyad price target lowered to $18 from $22 at H.C. Wainwright
ALXN Alexion
$181.90 /

+0.25 (+0.14%)

05/05/21
Fly Intel: Top five analyst upgrades
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
05/03/21 SVB Leerink
Alexion price target raised to $173 from $156 at SVB Leerink
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
XLRN Acceleron
$128.63 /

-2.39 (-1.82%)

VRTX Vertex Pharmaceuticals
$188.94 /

-5.87 (-3.01%)

TGTX TG Therapeutics
$37.42 /

-0.88 (-2.30%)

SGEN Seagen
$153.20 /

-2.99 (-1.91%)

RIGL Rigel Pharmaceuticals
$4.27 /

-0.1 (-2.29%)

QURE uniQure
$34.46 /

-0.43 (-1.23%)

ORTX Orchard Therapeutics
$4.85 /

-0.19 (-3.77%)

MGTA Magenta Therapeutics
$11.38 /

+0.05 (+0.44%)

MEIP MEI Pharma
$3.10 /

-0.15 (-4.62%)

MBIO Mustang Bio
$3.57 /

-0.115 (-3.13%)

KROS Keros Therapeutics
$52.55 /

-0.455 (-0.86%)

JAZZ Jazz Pharmaceuticals
$183.42 /

-2.7 (-1.45%)

INCY Incyte
$82.69 /

+0.11 (+0.13%)

IMRA Imara
$8.26 /

-0.44 (-5.06%)

GBT Global Blood Therapeutics
$39.60 /

-0.65 (-1.61%)

FMTX Forma Therapeutics
$24.13 /

-0.09 (-0.37%)

EQ Equillium
$6.05 /

+0.05 (+0.83%)

EPZM Epizyme
$8.79 /

-0.025 (-0.28%)

CRIS Curis
$7.61 /

-0.44 (-5.47%)

BGNE BeiGene
$332.97 /

-9.75 (-2.84%)

APTO Aptose Biosciences
$3.50 /

-0.21 (-5.66%)

APLS Apellis
$60.63 /

-4.27 (-6.58%)

ALXN Alexion
$181.90 /

+0.25 (+0.14%)

AGIO Agios Pharmaceuticals
$58.23 /

+0.04 (+0.07%)

  • 15
    Dec
  • 09
    Dec
  • 11
    Dec
  • 02
    Dec
  • 13
    Nov
  • 14
    Aug
  • 16
    Jul
  • 01
    Jul
  • 25
    Jun
  • 19
    Jun
VRTX Vertex Pharmaceuticals
$188.94 /

-5.87 (-3.01%)

RIGL Rigel Pharmaceuticals
$4.27 /

-0.1 (-2.29%)

ORTX Orchard Therapeutics
$4.85 /

-0.19 (-3.77%)

JAZZ Jazz Pharmaceuticals
$183.42 /

-2.7 (-1.45%)

INCY Incyte
$82.69 /

+0.11 (+0.13%)

EPZM Epizyme
$8.79 /

-0.025 (-0.28%)

VRTX Vertex Pharmaceuticals
$188.94 /

-5.87 (-3.01%)

TGTX TG Therapeutics
$37.42 /

-0.88 (-2.30%)

SGEN Seagen
$153.20 /

-2.99 (-1.91%)

QURE uniQure
$34.46 /

-0.43 (-1.23%)

MBIO Mustang Bio
$3.57 /

-0.115 (-3.13%)

JAZZ Jazz Pharmaceuticals
$183.42 /

-2.7 (-1.45%)

INCY Incyte
$82.69 /

+0.11 (+0.13%)

IMRA Imara
$8.26 /

-0.44 (-5.06%)

GBT Global Blood Therapeutics
$39.60 /

-0.65 (-1.61%)

EQ Equillium
$6.05 /

+0.05 (+0.83%)

CRIS Curis
$7.61 /

-0.44 (-5.47%)

APTO Aptose Biosciences
$3.50 /

-0.21 (-5.66%)

APLS Apellis
$60.63 /

-4.27 (-6.58%)

ALXN Alexion
$181.90 /

+0.25 (+0.14%)

VRTX Vertex Pharmaceuticals
$188.94 /

-5.87 (-3.01%)

INCY Incyte
$82.69 /

+0.11 (+0.13%)

FMTX Forma Therapeutics
$24.13 /

-0.09 (-0.37%)

EQ Equillium
$6.05 /

+0.05 (+0.83%)

CRIS Curis
$7.61 /

-0.44 (-5.47%)

APLS Apellis
$60.63 /

-4.27 (-6.58%)

ALXN Alexion
$181.90 /

+0.25 (+0.14%)

Yesterday
On The Fly
Wall Street in Fives - Must Read Lists for Tuesday » 16:25
06/15/21
06/15
16:25
06/15/21
16:25
BA

Boeing

$246.55 /

+1.48 (+0.60%)

, EADSY

Airbus

$34.33 /

+0.32 (+0.94%)

, NVAX

Novavax

$187.15 /

-21.05 (-10.11%)

, AZN

AstraZeneca

$58.84 /

+0.09 (+0.15%)

, AAPL

Apple

$129.75 /

-0.74 (-0.57%)

, GOOG

Alphabet

$2,520.68 /

-6.19 (-0.24%)

, GOOGL

Alphabet Class A

$2,428.41 /

-16.59 (-0.68%)

, NTDOY

Nintendo

$73.23 /

-1.05 (-1.41%)

, WPC

W.P. Carey

$77.61 /

-0.03 (-0.04%)

, CR

Crane

$91.81 /

+0.995 (+1.10%)

, ACRS

Aclaris Therapeutics

$17.73 /

-0.005 (-0.03%)

, CDAY

Ceridian

$84.54 /

-4.64 (-5.20%)

, FAST

Fastenal

$51.54 /

-1.19 (-2.26%)

, AMZN

Amazon.com

$3,381.76 /

-0.86 (-0.03%)

, DKNG

DraftKings

$48.51 /

-2.115 (-4.18%)

, DISH

Dish

$40.16 /

+0.135 (+0.34%)

, MSFT

Microsoft

$258.65 /

-1.3 (-0.50%)

, NFLX

Netflix

$492.17 /

-7.43 (-1.49%)

, OCGN

Ocugen

$6.28 /

+0.13 (+2.11%)

, ELAN

Elanco

$34.83 /

+1.33 (+3.97%)

, FOA

Finance of America

$8.85 /

+1.55 (+21.23%)

, SAGE

Sage Therapeutics

$59.00 /

-13.88 (-19.05%)

, VRM

Vroom

$40.01 /

-5.125 (-11.36%)

, SAVE

Spirit Airlines

$33.99 /

+0.035 (+0.10%)

, QD

Qudian

$2.39 /

-0.05 (-2.05%)

, BCOR

Blucora

$18.34 /

+1.37 (+8.07%)

, HLIO

Helios Technologies

$73.85 /

+1.88 (+2.61%)

, BBCP

Concrete Pumping

$8.43 /

-0.11 (-1.29%)

Get caught up quickly on…

ShowHide Related Items >><<
WPC W.P. Carey
$77.61 /

-0.03 (-0.04%)

VRM Vroom
$40.01 /

-5.125 (-11.36%)

SAVE Spirit Airlines
$33.99 /

+0.035 (+0.10%)

SAGE Sage Therapeutics
$59.00 /

-13.88 (-19.05%)

QD Qudian
$2.39 /

-0.05 (-2.05%)

OCGN Ocugen
$6.28 /

+0.13 (+2.11%)

NVAX Novavax
$187.15 /

-21.05 (-10.11%)

NTDOY Nintendo
$73.23 /

-1.05 (-1.41%)

NFLX Netflix
$492.17 /

-7.43 (-1.49%)

MSFT Microsoft
$258.65 /

-1.3 (-0.50%)

HLIO Helios Technologies
$73.85 /

+1.88 (+2.61%)

GOOG Alphabet
$2,520.68 /

-6.19 (-0.24%)

FOA Finance of America
$8.85 /

+1.55 (+21.23%)

FAST Fastenal
$51.54 /

-1.19 (-2.26%)

ELAN Elanco
$34.83 /

+1.33 (+3.97%)

EADSY Airbus
$34.33 /

+0.32 (+0.94%)

DKNG DraftKings
$48.51 /

-2.115 (-4.18%)

DISH Dish
$40.16 /

+0.135 (+0.34%)

CR Crane
$91.81 /

+0.995 (+1.10%)

CDAY Ceridian
$84.54 /

-4.64 (-5.20%)

BCOR Blucora
$18.34 /

+1.37 (+8.07%)

BBCP Concrete Pumping
$8.43 /

-0.11 (-1.29%)

BA Boeing
$246.55 /

+1.48 (+0.60%)

AZN AstraZeneca
$58.84 /

+0.09 (+0.15%)

AMZN Amazon.com
$3,381.76 /

-0.86 (-0.03%)

ACRS Aclaris Therapeutics
$17.73 /

-0.005 (-0.03%)

AAPL Apple
$129.75 /

-0.74 (-0.57%)

BA Boeing
$246.55 /

+1.48 (+0.60%)

06/15/21 Berenberg
Boeing price target raised to $245 from $215 at Berenberg
06/10/21 Jefferies
Boeing shares could move up 5% on China recertification, says Jefferies
06/09/21 Susquehanna
Boeing estimates lowered on light May deliveries, says Susquehanna
06/03/21 Morgan Stanley
Morgan Stanley says recovery tailwinds can offset new launch headwinds at Boeing
EADSY Airbus
$34.33 /

+0.32 (+0.94%)

06/15/21 Berenberg
Airbus price target raised to EUR 140 from EUR 110 at Berenberg
06/11/21 Credit Suisse
Airbus assumed with an Outperform at Credit Suisse
06/02/21 Barclays
Airbus price target raised to EUR 138 from EUR 113 at Barclays
06/02/21
Fly Intel: Top five analyst upgrades
NVAX Novavax
$187.15 /

-21.05 (-10.11%)

06/15/21 Cantor Fitzgerald
Novavax price target raised to $272 from $217 at Cantor Fitzgerald
06/07/21 B. Riley
Novavax risk/reward attractive into Covid vaccine data, says B. Riley
05/12/21
Fly Intel: Top five analyst downgrades
05/12/21 B. Riley
Novavax price target lowered to $286 from $365 at B. Riley
AZN AstraZeneca
$58.84 /

+0.09 (+0.15%)

06/01/21 Piper Sandler
Piper sees 'quite real' chance of Akebia's vadadustat being first HIF approved
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
AAPL Apple
$129.75 /

-0.74 (-0.57%)

06/11/21 Argus
Apple underperformance due to sector rotation, not misfires, says Argus
06/08/21 RBC Capital
Fisker initiated with an Outperform at RBC Capital
06/08/21 BofA
Apple App store growth decelerating in Q3 to-date, says BofA
06/08/21 Wedbush
Apple WWDC 'all about iOS 15, new Macs,' says Wedbush
GOOG Alphabet
$2,520.68 /

-6.19 (-0.24%)

06:30 Today Jefferies
Jefferies adds Amazon.com to Franchise Picks list, removes Alphabet
06/11/21 Tigress Financial
Tigress sees Alphabet shares rising to $3,185 in 12 months
06/02/21 KGI Securities
Alphabet initiated with an Outperform at KGI Securities
05/19/21 JPMorgan
Broadcom continues to win AI chip work at Google, says JPMorgan
GOOGL Alphabet Class A
$2,428.41 /

-16.59 (-0.68%)

06/08/21 UBS
Snowflake price target raised to $300 from $275 at UBS
NTDOY Nintendo
$73.23 /

-1.05 (-1.41%)

05/21/21 Citi
Nintendo downgraded to Neutral from Buy at Citi
11/06/20 DZ Bank
Nintendo upgraded to Buy from Sell at DZ Bank
09/10/20 Jefferies
Nintendo upgraded to Buy on WFH boost at Jefferies
09/10/20 Jefferies
Nintendo upgraded to Buy from Hold at Jefferies
WPC W.P. Carey
$77.61 /

-0.03 (-0.04%)

06/15/21
Fly Intel: Top five analyst upgrades
06/15/21 JPMorgan
JPMorgan upgrades W.P. Carey on swap out of Broadstone
06/15/21 JPMorgan
W.P. Carey upgraded to Overweight from Neutral at JPMorgan
05/03/21 Evercore ISI
W.P. Carey upgraded to Outperform at Evercore ISI on accelerating acquisitions
CR Crane
$91.81 /

+0.995 (+1.10%)

06/15/21 DA Davidson
Crane upgraded to Buy at DA Davidson following Engineered Materials divestment
06/15/21 DA Davidson
Crane upgraded to Buy from Neutral at DA Davidson
05/05/21 DA Davidson
Crane price target raised to $105 from $85 at DA Davidson
ACRS Aclaris Therapeutics
$17.73 /

-0.005 (-0.03%)

06:13 Today H.C. Wainwright
Aclaris Therapeutics price target raised to $50 from $40 at H.C. Wainwright
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Piper Sandler
Aclaris Therapeutics initiated with an Overweight at Piper Sandler
04/21/21 H.C. Wainwright
Aclaris Therapeutics initiated with a Buy at H.C. Wainwright
CDAY Ceridian
$84.54 /

-4.64 (-5.20%)

06/15/21
Fly Intel: Top five analyst downgrades
06/15/21 Needham
Ceridian downgraded to Hold from Buy at Needham
05/28/21 Jefferies
Ceridian price target lowered to $95 from $110 at Jefferies
05/06/21 Mizuho
Ceridian price target raised to $120 from $110 at Mizuho
FAST Fastenal
$51.54 /

-1.19 (-2.26%)

06/15/21 Morgan Stanley
Fastenal downgraded to Underweight from Equal Weight at Morgan Stanley
06/04/21 Raymond James
Fastenal's May ADS down 3.2% off challenging comparison, says Raymond James
05/03/21 Raymond James
Grainger price target raised to $460 from $400 at Raymond James
AMZN Amazon.com
$3,381.76 /

-0.86 (-0.03%)

07:18 Today JPMorgan
JPMorgan values Amazon Prime at $1,000 per year, 8.5 times actual price
04:48 Today Pivotal Research
Dish upgraded to Buy from Hold at Pivotal Research
06/15/21 JPMorgan
Amazon should surpass Walmart as largest retailer in 2022, says JPMorgan
DKNG DraftKings
$48.51 /

-2.115 (-4.18%)

07:11 Today Susquehanna
DraftKings report referenced allegations prior to acquisition, says Susquehanna
06:57 Today Morgan Stanley
Morgan Stanley says DraftKings opportunity around core U.S. business, not SBTech
06/15/21 Credit Suisse
DraftKings selloff on short report overdone, says Credit Suisse
06/02/21 Morgan Stanley
DraftKings price target lowered to $58 from $63 at Morgan Stanley
DISH Dish
$40.16 /

+0.135 (+0.34%)

06/09/21
Fly Intel: Top five analyst downgrades
06/09/21 JPMorgan
JPMorgan downgrades Dish to sell on wireless execution concerns
06/09/21 JPMorgan
Dish downgraded to Underweight from Neutral at JPMorgan
MSFT Microsoft
$258.65 /

-1.3 (-0.50%)

06/15/21 Oppenheimer
Turtle Beach price target raised to $45 from $40 at Oppenheimer
06/07/21 Morgan Stanley
Microsoft valuation presents 'attractive entry point,' says Morgan Stanley
06/03/21 Tigress Financial
Microsoft shares going to $303 in 12 months, says Tigress Financial
06/01/21 KGI Securities
Microsoft initiated with an Outperform at KGI Securities
NFLX Netflix
$492.17 /

-7.43 (-1.49%)

07:23 Today JPMorgan
JPMorgan 'incrementally positive' on Netflix into second half content slate
06/01/21 KGI Securities
Netflix initiated with a Neutral at KGI Securities
05/27/21 Stifel
Stifel sees 'minimal impact' to Netflix from Amazon's MGM acquisition
05/27/21 Benchmark
Streaming field 'looking ever less unipolar around Netflix,' says Benchmark
OCGN Ocugen
$6.28 /

+0.13 (+2.11%)

06/11/21
Fly Intel: Top five analyst downgrades
06/11/21 H.C. Wainwright
Ocugen price target lowered to $10 from $12 at H.C. Wainwright
06/10/21 Roth Capital
Ocugen downgraded to Neutral from Buy at Roth Capital
06/10/21 Chardan
Ocugen price target lowered to $4.50 from $8 at Chardan
ELAN Elanco
$34.83 /

+1.33 (+3.97%)

06/15/21 Cleveland Research
Elanco upgraded to Neutral from Underperform at Cleveland Research
05/17/21 Citi
Elanco price target raised to $42 from $39 at Citi
05/11/21 Gabelli
Elanco upgraded to Buy from Hold at Gabelli
05/11/21 Barclays
Elanco upgraded to Equal Weight from Underweight at Barclays
FOA Finance of America
$8.85 /

+1.55 (+21.23%)

06/15/21 Raymond James
Finance of America upgraded to Strong Buy from Outperform at Raymond James
06/15/21 Raymond James
Finance of America upgraded to Strong Buy from Outperform at Raymond James
04/23/21 Raymond James
First of America initiated with an Outperform at Raymond James
SAGE Sage Therapeutics
$59.00 /

-13.88 (-19.05%)

07:42 Today William Blair
Sage Therapeutics downgraded to Market Perform from Outperform at William Blair
07:12 Today BMO Capital
Sage Therapeutics price target lowered to $73 from $87 at BMO Capital
06:35 Today Citi
Sage Therapeutics downgraded to Neutral from Buy at Citi
06/15/21 Piper Sandler
Street 'unfairly penalizing' Sage depression drug, says Piper Sandler
VRM Vroom
$40.01 /

-5.125 (-11.36%)

05/13/21 Raymond James
Vroom price target raised to $53 from $47 at Raymond James
05/13/21 JMP Securities
Vroom price target raised to $55 from $48 at JMP Securities
05/13/21 Piper Sandler
Vroom price target lowered to $58 from $60 at Piper Sandler
04/13/21 Wedbush
Vroom added to Best List Ideas at Wedbush
SAVE Spirit Airlines
$33.99 /

+0.035 (+0.10%)

06/15/21 Citi
Spirit Airlines upgraded to Buy from Neutral at Citi
06/09/21 MKM Partners
MKM sees 'a lot to like' in Spirit Airlines' valuation
06/09/21 MKM Partners
Spirit Airlines initiated with a Buy at MKM Partners
QD Qudian
$2.39 /

-0.05 (-2.05%)

BCOR Blucora
$18.34 /

+1.37 (+8.07%)

04/01/21 JPMorgan
Blucora assumed with an Overweight at JPMorgan
02/17/21 Barrington
Blucora price target raised to $19 from $16 at Barrington
08/05/20 Barrington
Blucora price target lowered to $15 from $18 at Barrington
HLIO Helios Technologies
$73.85 /

+1.88 (+2.61%)

06/15/21 Baird
Helios Technologies price target raised to $94 from $89 at Baird
05/11/21 Baird
Helios Technologies price target raised to $89 from $84 at Baird
05/11/21 Baird
Helios Technologies updated guidance above previous range, says Baird
03/02/21 Baird
Helios Technologies price target raised to $82 from $72 at Baird
BBCP Concrete Pumping
$8.43 /

-0.11 (-1.29%)

06/15/21 Baird
Concrete Pumping price target raised to $11 from $10 at Baird
04/22/21 Baird
Concrete Pumping price target raised to $9 from $8 at Baird
01/13/21 B. Riley
Concrete Pumping price target lowered to $6 from $6.75 at B. Riley Securities
01/07/21 B. Riley
Concrete Pumping price target raised to $6.75 from $6.50 at B. Riley Securities
WPC W.P. Carey
$77.61 /

-0.03 (-0.04%)

VRM Vroom
$40.01 /

-5.125 (-11.36%)

SAVE Spirit Airlines
$33.99 /

+0.035 (+0.10%)

SAGE Sage Therapeutics
$59.00 /

-13.88 (-19.05%)

QD Qudian
$2.39 /

-0.05 (-2.05%)

OCGN Ocugen
$6.28 /

+0.13 (+2.11%)

NVAX Novavax
$187.15 /

-21.05 (-10.11%)

NTDOY Nintendo
$73.23 /

-1.05 (-1.41%)

NFLX Netflix
$492.17 /

-7.43 (-1.49%)

MSFT Microsoft
$258.65 /

-1.3 (-0.50%)

HLIO Helios Technologies
$73.85 /

+1.88 (+2.61%)

GOOG Alphabet
$2,520.68 /

-6.19 (-0.24%)

FAST Fastenal
$51.54 /

-1.19 (-2.26%)

ELAN Elanco
$34.83 /

+1.33 (+3.97%)

EADSY Airbus
$34.33 /

+0.32 (+0.94%)

DKNG DraftKings
$48.51 /

-2.115 (-4.18%)

DISH Dish
$40.16 /

+0.135 (+0.34%)

CR Crane
$91.81 /

+0.995 (+1.10%)

CDAY Ceridian
$84.54 /

-4.64 (-5.20%)

BCOR Blucora
$18.34 /

+1.37 (+8.07%)

BBCP Concrete Pumping
$8.43 /

-0.11 (-1.29%)

BA Boeing
$246.55 /

+1.48 (+0.60%)

AZN AstraZeneca
$58.84 /

+0.09 (+0.15%)

AMZN Amazon.com
$3,381.76 /

-0.86 (-0.03%)

ACRS Aclaris Therapeutics
$17.73 /

-0.005 (-0.03%)

AAPL Apple
$129.75 /

-0.74 (-0.57%)

  • 10
    Jun
  • 08
    Jun
  • 20
    Jan
  • 07
    Dec
  • 01
    Dec
  • 19
    Nov
  • 07
    Oct
  • 11
    Sep
  • 26
    Aug
  • 18
    Jun
  • 19
    Jun
VRM Vroom
$40.01 /

-5.125 (-11.36%)

SAVE Spirit Airlines
$33.99 /

+0.035 (+0.10%)

OCGN Ocugen
$6.28 /

+0.13 (+2.11%)

NVAX Novavax
$187.15 /

-21.05 (-10.11%)

NTDOY Nintendo
$73.23 /

-1.05 (-1.41%)

NFLX Netflix
$492.17 /

-7.43 (-1.49%)

MSFT Microsoft
$258.65 /

-1.3 (-0.50%)

GOOG Alphabet
$2,520.68 /

-6.19 (-0.24%)

ELAN Elanco
$34.83 /

+1.33 (+3.97%)

EADSY Airbus
$34.33 /

+0.32 (+0.94%)

DKNG DraftKings
$48.51 /

-2.115 (-4.18%)

DISH Dish
$40.16 /

+0.135 (+0.34%)

CR Crane
$91.81 /

+0.995 (+1.10%)

BA Boeing
$246.55 /

+1.48 (+0.60%)

AZN AstraZeneca
$58.84 /

+0.09 (+0.15%)

AMZN Amazon.com
$3,381.76 /

-0.86 (-0.03%)

AAPL Apple
$129.75 /

-0.74 (-0.57%)

VRM Vroom
$40.01 /

-5.125 (-11.36%)

NVAX Novavax
$187.15 /

-21.05 (-10.11%)

NTDOY Nintendo
$73.23 /

-1.05 (-1.41%)

NFLX Netflix
$492.17 /

-7.43 (-1.49%)

HLIO Helios Technologies
$73.85 /

+1.88 (+2.61%)

GOOG Alphabet
$2,520.68 /

-6.19 (-0.24%)

FAST Fastenal
$51.54 /

-1.19 (-2.26%)

ELAN Elanco
$34.83 /

+1.33 (+3.97%)

DKNG DraftKings
$48.51 /

-2.115 (-4.18%)

DISH Dish
$40.16 /

+0.135 (+0.34%)

CR Crane
$91.81 /

+0.995 (+1.10%)

CDAY Ceridian
$84.54 /

-4.64 (-5.20%)

BA Boeing
$246.55 /

+1.48 (+0.60%)

AZN AstraZeneca
$58.84 /

+0.09 (+0.15%)

AMZN Amazon.com
$3,381.76 /

-0.86 (-0.03%)

ACRS Aclaris Therapeutics
$17.73 /

-0.005 (-0.03%)

AAPL Apple
$129.75 /

-0.74 (-0.57%)

VRM Vroom
$40.01 /

-5.125 (-11.36%)

SAVE Spirit Airlines
$33.99 /

+0.035 (+0.10%)

QD Qudian
$2.39 /

-0.05 (-2.05%)

OCGN Ocugen
$6.28 /

+0.13 (+2.11%)

NVAX Novavax
$187.15 /

-21.05 (-10.11%)

NFLX Netflix
$492.17 /

-7.43 (-1.49%)

MSFT Microsoft
$258.65 /

-1.3 (-0.50%)

GOOGL Alphabet Class A
$2,428.41 /

-16.59 (-0.68%)

GOOG Alphabet
$2,520.68 /

-6.19 (-0.24%)

FOA Finance of America
$8.85 /

+1.55 (+21.23%)

DKNG DraftKings
$48.51 /

-2.115 (-4.18%)

DISH Dish
$40.16 /

+0.135 (+0.34%)

BA Boeing
$246.55 /

+1.48 (+0.60%)

AZN AstraZeneca
$58.84 /

+0.09 (+0.15%)

AMZN Amazon.com
$3,381.76 /

-0.86 (-0.03%)

AAPL Apple
$129.75 /

-0.74 (-0.57%)

Recommendations
Jounce Therapeutics receives $25M milestone from Gilead, says Piper Sandler » 12:22
06/15/21
06/15
12:22
06/15/21
12:22
JNCE

Jounce Therapeutics

$7.84 /

+0.87 (+12.48%)

, GILD

Gilead

$67.89 /

-0.26 (-0.38%)

Piper Sandler analyst…

Piper Sandler analyst Edward Tenthoff reiterates an Overweight rating and $20 price target on Jounce Therapeutics (JNCE), which will receive a $25M milestone from partner Gilead (GILD) for IND clearance for anti-CCR8 antibody GS-1811. Jounce, which expects to initiate eight expansion cohorts in 2H21, now holds pro forma cash of roughly $296M to advance its innovative I-O pipeline, Tenthoff tells investors in a research note.

ShowHide Related Items >><<
JNCE Jounce Therapeutics
$7.84 /

+0.87 (+12.48%)

GILD Gilead
$67.89 /

-0.26 (-0.38%)

JNCE Jounce Therapeutics
$7.84 /

+0.87 (+12.48%)

04/12/21 Roth Capital
Jounce reported 'very robust' JTX-8064 analysis, says Roth Capital
03/14/21 Piper Sandler
Jounce Therapeutics initiated with an Overweight at Piper Sandler
02/26/21 H.C. Wainwright
Jounce Therapeutics price target raised to $15 from $11 at H.C. Wainwright
12/04/20 H.C. Wainwright
Jounce Therapeutics assumed with a Buy at H.C. Wainwright
GILD Gilead
$67.89 /

-0.26 (-0.38%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
JNCE Jounce Therapeutics
$7.84 /

+0.87 (+12.48%)

GILD Gilead
$67.89 /

-0.26 (-0.38%)

  • 10
    Mar
GILD Gilead
$67.89 /

-0.26 (-0.38%)

JNCE Jounce Therapeutics
$7.84 /

+0.87 (+12.48%)

GILD Gilead
$67.89 /

-0.26 (-0.38%)

GILD Gilead
$67.89 /

-0.26 (-0.38%)

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:06
06/15/21
06/15
12:06
06/15/21
12:06
BA

Boeing

$245.71 /

+0.64 (+0.26%)

, EADSY

Airbus

$34.01 /

-0.02 (-0.06%)

, NVAX

Novavax

$189.20 /

-19 (-9.13%)

, AZN

AstraZeneca

$58.62 /

-0.13 (-0.22%)

, CLSD

Clearside Biomedical

$3.84 /

+0.8 (+26.32%)

, DCRC

Decarbonization Plus Acquisition III

$10.72 /

-1.31 (-10.89%)

, WPC

W.P. Carey

$77.50 /

-0.14 (-0.18%)

, CR

Crane

$91.42 /

+0.61 (+0.67%)

, ACRS

Aclaris Therapeutics

$17.59 /

-0.14 (-0.79%)

, CDAY

Ceridian

$85.53 /

-3.65 (-4.09%)

, FAST

Fastenal

$51.70 /

-1.03 (-1.95%)

, AMZN

Amazon.com

$3,371.43 /

-11.19 (-0.33%)

, DKNG

DraftKings

$48.28 /

-2.34 (-4.62%)

, DISH

Dish

$39.69 /

-0.335 (-0.84%)

, MSFT

Microsoft

$259.24 /

-0.71 (-0.27%)

, NFLX

Netflix

$494.25 /

-5.35 (-1.07%)

, OCGN

Ocugen

$6.59 /

+0.44 (+7.15%)

, ELAN

Elanco

$35.23 /

+1.73 (+5.16%)

, FOA

Finance of America

$8.83 /

+1.53 (+20.96%)

, SAGE

Sage Therapeutics

$60.33 /

-12.55 (-17.22%)

, VRM

Vroom

$40.55 /

-4.58 (-10.15%)

, SAVE

Spirit Airlines

$33.83 /

-0.125 (-0.37%)

, QD

Qudian

$2.25 /

-0.19 (-7.79%)

, BCOR

Blucora

$18.37 /

+1.4 (+8.25%)

, HLIO

Helios Technologies

$72.61 /

+0.64 (+0.89%)

, BBCP

Concrete Pumping

$8.44 /

-0.1 (-1.17%)

Get caught up quickly on…

ShowHide Related Items >><<
WPC W.P. Carey
$77.50 /

-0.14 (-0.18%)

VRM Vroom
$40.55 /

-4.58 (-10.15%)

SAVE Spirit Airlines
$33.83 /

-0.125 (-0.37%)

SAGE Sage Therapeutics
$60.33 /

-12.55 (-17.22%)

QD Qudian
$2.25 /

-0.19 (-7.79%)

OCGN Ocugen
$6.59 /

+0.44 (+7.15%)

NVAX Novavax
$189.20 /

-19 (-9.13%)

NFLX Netflix
$494.25 /

-5.35 (-1.07%)

MSFT Microsoft
$259.24 /

-0.71 (-0.27%)

HLIO Helios Technologies
$72.61 /

+0.64 (+0.89%)

FOA Finance of America
$8.83 /

+1.53 (+20.96%)

FAST Fastenal
$51.70 /

-1.03 (-1.95%)

ELAN Elanco
$35.23 /

+1.73 (+5.16%)

EADSY Airbus
$34.01 /

-0.02 (-0.06%)

DKNG DraftKings
$48.28 /

-2.34 (-4.62%)

DISH Dish
$39.69 /

-0.335 (-0.84%)

DCRC Decarbonization Plus Acquisition III
$10.72 /

-1.31 (-10.89%)

CR Crane
$91.42 /

+0.61 (+0.67%)

CLSD Clearside Biomedical
$3.84 /

+0.8 (+26.32%)

CDAY Ceridian
$85.53 /

-3.65 (-4.09%)

BCOR Blucora
$18.37 /

+1.4 (+8.25%)

BBCP Concrete Pumping
$8.44 /

-0.1 (-1.17%)

BA Boeing
$245.71 /

+0.64 (+0.26%)

AZN AstraZeneca
$58.62 /

-0.13 (-0.22%)

AMZN Amazon.com
$3,371.43 /

-11.19 (-0.33%)

ACRS Aclaris Therapeutics
$17.59 /

-0.14 (-0.79%)

BA Boeing
$245.71 /

+0.64 (+0.26%)

06/15/21 Berenberg
Boeing price target raised to $245 from $215 at Berenberg
06/10/21 Jefferies
Boeing shares could move up 5% on China recertification, says Jefferies
06/09/21 Susquehanna
Boeing estimates lowered on light May deliveries, says Susquehanna
06/03/21 Morgan Stanley
Morgan Stanley says recovery tailwinds can offset new launch headwinds at Boeing
EADSY Airbus
$34.01 /

-0.02 (-0.06%)

06/15/21 Berenberg
Airbus price target raised to EUR 140 from EUR 110 at Berenberg
06/11/21 Credit Suisse
Airbus assumed with an Outperform at Credit Suisse
06/02/21 Barclays
Airbus price target raised to EUR 138 from EUR 113 at Barclays
06/02/21
Fly Intel: Top five analyst upgrades
NVAX Novavax
$189.20 /

-19 (-9.13%)

06/15/21 Cantor Fitzgerald
Novavax price target raised to $272 from $217 at Cantor Fitzgerald
06/07/21 B. Riley
Novavax risk/reward attractive into Covid vaccine data, says B. Riley
05/12/21
Fly Intel: Top five analyst downgrades
05/12/21 B. Riley
Novavax price target lowered to $286 from $365 at B. Riley
AZN AstraZeneca
$58.62 /

-0.13 (-0.22%)

06/01/21 Piper Sandler
Piper sees 'quite real' chance of Akebia's vadadustat being first HIF approved
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
CLSD Clearside Biomedical
$3.84 /

+0.8 (+26.32%)

06/15/21 Roth Capital
Clearside reported 'impressive' data in wet AMD, says Roth Capital
06/02/21 Roth Capital
Clearside success with Xipere can derisk pipeline, says Roth Capital
05/18/21 Roth Capital
Clearside Biomedical price target raised to $9 from $8 at Roth Capital
03/02/21 Roth Capital
Clearside enrollment speed 'encouraging,' says Roth Capital
DCRC Decarbonization Plus Acquisition III
$10.72 /

-1.31 (-10.89%)

WPC W.P. Carey
$77.50 /

-0.14 (-0.18%)

06/15/21
Fly Intel: Top five analyst upgrades
06/15/21 JPMorgan
JPMorgan upgrades W.P. Carey on swap out of Broadstone
06/15/21 JPMorgan
W.P. Carey upgraded to Overweight from Neutral at JPMorgan
05/03/21 Evercore ISI
W.P. Carey upgraded to Outperform at Evercore ISI on accelerating acquisitions
CR Crane
$91.42 /

+0.61 (+0.67%)

06/15/21 DA Davidson
Crane upgraded to Buy at DA Davidson following Engineered Materials divestment
06/15/21 DA Davidson
Crane upgraded to Buy from Neutral at DA Davidson
05/05/21 DA Davidson
Crane price target raised to $105 from $85 at DA Davidson
ACRS Aclaris Therapeutics
$17.59 /

-0.14 (-0.79%)

06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Piper Sandler
Aclaris Therapeutics initiated with an Overweight at Piper Sandler
04/21/21 H.C. Wainwright
Aclaris Therapeutics initiated with a Buy at H.C. Wainwright
03/04/21 SVB Leerink
Aclaris Therapeutics price target raised to $26 from $21 at SVB Leerink
CDAY Ceridian
$85.53 /

-3.65 (-4.09%)

06/15/21
Fly Intel: Top five analyst downgrades
06/15/21 Needham
Ceridian downgraded to Hold from Buy at Needham
05/28/21 Jefferies
Ceridian price target lowered to $95 from $110 at Jefferies
05/06/21 Mizuho
Ceridian price target raised to $120 from $110 at Mizuho
FAST Fastenal
$51.70 /

-1.03 (-1.95%)

06/15/21 Morgan Stanley
Fastenal downgraded to Underweight from Equal Weight at Morgan Stanley
06/04/21 Raymond James
Fastenal's May ADS down 3.2% off challenging comparison, says Raymond James
05/03/21 Raymond James
Grainger price target raised to $460 from $400 at Raymond James
AMZN Amazon.com
$3,371.43 /

-11.19 (-0.33%)

06/15/21 JPMorgan
Amazon should surpass Walmart as largest retailer in 2022, says JPMorgan
06/14/21 Evercore ISI
Synchrony price target raised to $56 from $49 at Evercore ISI
06/08/21 Piper Sandler
New Amazon offering targets Hims & Hers and others, says Piper Sandler
06/08/21 UBS
Snowflake price target raised to $300 from $275 at UBS
DKNG DraftKings
$48.28 /

-2.34 (-4.62%)

06/15/21 Credit Suisse
DraftKings selloff on short report overdone, says Credit Suisse
06/02/21 Morgan Stanley
DraftKings price target lowered to $58 from $63 at Morgan Stanley
05/24/21 Argus
DraftKings price target lowered to $60 from $78 at Argus
05/12/21
Fly Intel: Top five analyst upgrades
DISH Dish
$39.69 /

-0.335 (-0.84%)

06/09/21
Fly Intel: Top five analyst downgrades
06/09/21 JPMorgan
JPMorgan downgrades Dish to sell on wireless execution concerns
06/09/21 JPMorgan
Dish downgraded to Underweight from Neutral at JPMorgan
05/24/21 HSBC
Dish price target raised to $40 from $26 at HSBC
MSFT Microsoft
$259.24 /

-0.71 (-0.27%)

06/15/21 Oppenheimer
Turtle Beach price target raised to $45 from $40 at Oppenheimer
06/07/21 Morgan Stanley
Microsoft valuation presents 'attractive entry point,' says Morgan Stanley
06/03/21 Tigress Financial
Microsoft shares going to $303 in 12 months, says Tigress Financial
06/01/21 KGI Securities
Microsoft initiated with an Outperform at KGI Securities
NFLX Netflix
$494.25 /

-5.35 (-1.07%)

06/01/21 KGI Securities
Netflix initiated with a Neutral at KGI Securities
05/27/21 Stifel
Stifel sees 'minimal impact' to Netflix from Amazon's MGM acquisition
05/27/21 Benchmark
Streaming field 'looking ever less unipolar around Netflix,' says Benchmark
05/26/21 Piper Sandler
Amazon deal to buy MGM Studios 'looks sensible,' says Piper Sandler
OCGN Ocugen
$6.59 /

+0.44 (+7.15%)

06/11/21
Fly Intel: Top five analyst downgrades
06/11/21 H.C. Wainwright
Ocugen price target lowered to $10 from $12 at H.C. Wainwright
06/10/21 Roth Capital
Ocugen downgraded to Neutral from Buy at Roth Capital
06/10/21 Chardan
Ocugen price target lowered to $4.50 from $8 at Chardan
ELAN Elanco
$35.23 /

+1.73 (+5.16%)

06/15/21 Cleveland Research
Elanco upgraded to Neutral from Underperform at Cleveland Research
05/17/21 Citi
Elanco price target raised to $42 from $39 at Citi
05/11/21 Gabelli
Elanco upgraded to Buy from Hold at Gabelli
05/11/21 Barclays
Elanco upgraded to Equal Weight from Underweight at Barclays
FOA Finance of America
$8.83 /

+1.53 (+20.96%)

06/15/21 Raymond James
Finance of America upgraded to Strong Buy from Outperform at Raymond James
06/15/21 Raymond James
Finance of America upgraded to Strong Buy from Outperform at Raymond James
04/23/21 Raymond James
First of America initiated with an Outperform at Raymond James
SAGE Sage Therapeutics
$60.33 /

-12.55 (-17.22%)

06/15/21 Stifel
Sage, Biogen data support FDA approval in depression, says Stifel
06/15/21 Piper Sandler
Sage selloff on zuranolone data an overreaction, says Piper Sandler
05/05/21 Mizuho
Sage Therapeutics price target lowered to $77 from $81 at Mizuho
04/12/21 Oppenheimer
Sage Therapeutics data support 'enthusiasm' for SAGE-324 in ET, says Oppenheimer
VRM Vroom
$40.55 /

-4.58 (-10.15%)

05/13/21 Raymond James
Vroom price target raised to $53 from $47 at Raymond James
05/13/21 JMP Securities
Vroom price target raised to $55 from $48 at JMP Securities
05/13/21 Piper Sandler
Vroom price target lowered to $58 from $60 at Piper Sandler
04/13/21 Wedbush
Vroom added to Best List Ideas at Wedbush
SAVE Spirit Airlines
$33.83 /

-0.125 (-0.37%)

06/15/21 Citi
Spirit Airlines upgraded to Buy from Neutral at Citi
06/09/21 MKM Partners
MKM sees 'a lot to like' in Spirit Airlines' valuation
06/09/21 MKM Partners
Spirit Airlines initiated with a Buy at MKM Partners
QD Qudian
$2.25 /

-0.19 (-7.79%)

06/16/20 China Renaissance
China Renaissance ups LexinFintech to Buy, raises Fintech sector to Overweight
BCOR Blucora
$18.37 /

+1.4 (+8.25%)

04/01/21 JPMorgan
Blucora assumed with an Overweight at JPMorgan
02/17/21 Barrington
Blucora price target raised to $19 from $16 at Barrington
08/05/20 Barrington
Blucora price target lowered to $15 from $18 at Barrington
HLIO Helios Technologies
$72.61 /

+0.64 (+0.89%)

05/11/21 Baird
Helios Technologies price target raised to $89 from $84 at Baird
05/11/21 Baird
Helios Technologies updated guidance above previous range, says Baird
03/02/21 Baird
Helios Technologies price target raised to $82 from $72 at Baird
10/12/20 Baird
Helios Technologies upgraded to Outperform from Neutral at Baird
BBCP Concrete Pumping
$8.44 /

-0.1 (-1.17%)

06/15/21 Baird
Concrete Pumping price target raised to $11 from $10 at Baird
04/22/21 Baird
Concrete Pumping price target raised to $9 from $8 at Baird
01/13/21 B. Riley
Concrete Pumping price target lowered to $6 from $6.75 at B. Riley Securities
01/07/21 B. Riley
Concrete Pumping price target raised to $6.75 from $6.50 at B. Riley Securities
WPC W.P. Carey
$77.50 /

-0.14 (-0.18%)

VRM Vroom
$40.55 /

-4.58 (-10.15%)

SAVE Spirit Airlines
$33.83 /

-0.125 (-0.37%)

SAGE Sage Therapeutics
$60.33 /

-12.55 (-17.22%)

QD Qudian
$2.25 /

-0.19 (-7.79%)

OCGN Ocugen
$6.59 /

+0.44 (+7.15%)

NVAX Novavax
$189.20 /

-19 (-9.13%)

NFLX Netflix
$494.25 /

-5.35 (-1.07%)

MSFT Microsoft
$259.24 /

-0.71 (-0.27%)

HLIO Helios Technologies
$72.61 /

+0.64 (+0.89%)

FAST Fastenal
$51.70 /

-1.03 (-1.95%)

ELAN Elanco
$35.23 /

+1.73 (+5.16%)

EADSY Airbus
$34.01 /

-0.02 (-0.06%)

DKNG DraftKings
$48.28 /

-2.34 (-4.62%)

DISH Dish
$39.69 /

-0.335 (-0.84%)

CR Crane
$91.42 /

+0.61 (+0.67%)

CLSD Clearside Biomedical
$3.84 /

+0.8 (+26.32%)

CDAY Ceridian
$85.53 /

-3.65 (-4.09%)

BCOR Blucora
$18.37 /

+1.4 (+8.25%)

BBCP Concrete Pumping
$8.44 /

-0.1 (-1.17%)

BA Boeing
$245.71 /

+0.64 (+0.26%)

AZN AstraZeneca
$58.62 /

-0.13 (-0.22%)

AMZN Amazon.com
$3,371.43 /

-11.19 (-0.33%)

ACRS Aclaris Therapeutics
$17.59 /

-0.14 (-0.79%)

  • 10
    Jun
  • 08
    Jun
  • 20
    Jan
  • 07
    Dec
  • 01
    Dec
  • 19
    Nov
  • 07
    Oct
  • 11
    Sep
  • 26
    Aug
  • 18
    Jun
  • 19
    Jun
VRM Vroom
$40.55 /

-4.58 (-10.15%)

SAVE Spirit Airlines
$33.83 /

-0.125 (-0.37%)

OCGN Ocugen
$6.59 /

+0.44 (+7.15%)

NVAX Novavax
$189.20 /

-19 (-9.13%)

NFLX Netflix
$494.25 /

-5.35 (-1.07%)

MSFT Microsoft
$259.24 /

-0.71 (-0.27%)

ELAN Elanco
$35.23 /

+1.73 (+5.16%)

EADSY Airbus
$34.01 /

-0.02 (-0.06%)

DKNG DraftKings
$48.28 /

-2.34 (-4.62%)

DISH Dish
$39.69 /

-0.335 (-0.84%)

DCRC Decarbonization Plus Acquisition III
$10.72 /

-1.31 (-10.89%)

CR Crane
$91.42 /

+0.61 (+0.67%)

BA Boeing
$245.71 /

+0.64 (+0.26%)

AZN AstraZeneca
$58.62 /

-0.13 (-0.22%)

AMZN Amazon.com
$3,371.43 /

-11.19 (-0.33%)

VRM Vroom
$40.55 /

-4.58 (-10.15%)

SAVE Spirit Airlines
$33.83 /

-0.125 (-0.37%)

OCGN Ocugen
$6.59 /

+0.44 (+7.15%)

NVAX Novavax
$189.20 /

-19 (-9.13%)

NFLX Netflix
$494.25 /

-5.35 (-1.07%)

MSFT Microsoft
$259.24 /

-0.71 (-0.27%)

HLIO Helios Technologies
$72.61 /

+0.64 (+0.89%)

FAST Fastenal
$51.70 /

-1.03 (-1.95%)

ELAN Elanco
$35.23 /

+1.73 (+5.16%)

DKNG DraftKings
$48.28 /

-2.34 (-4.62%)

DISH Dish
$39.69 /

-0.335 (-0.84%)

DCRC Decarbonization Plus Acquisition III
$10.72 /

-1.31 (-10.89%)

CR Crane
$91.42 /

+0.61 (+0.67%)

CDAY Ceridian
$85.53 /

-3.65 (-4.09%)

BBCP Concrete Pumping
$8.44 /

-0.1 (-1.17%)

BA Boeing
$245.71 /

+0.64 (+0.26%)

AZN AstraZeneca
$58.62 /

-0.13 (-0.22%)

AMZN Amazon.com
$3,371.43 /

-11.19 (-0.33%)

ACRS Aclaris Therapeutics
$17.59 /

-0.14 (-0.79%)

VRM Vroom
$40.55 /

-4.58 (-10.15%)

SAVE Spirit Airlines
$33.83 /

-0.125 (-0.37%)

QD Qudian
$2.25 /

-0.19 (-7.79%)

OCGN Ocugen
$6.59 /

+0.44 (+7.15%)

NVAX Novavax
$189.20 /

-19 (-9.13%)

NFLX Netflix
$494.25 /

-5.35 (-1.07%)

MSFT Microsoft
$259.24 /

-0.71 (-0.27%)

FOA Finance of America
$8.83 /

+1.53 (+20.96%)

DKNG DraftKings
$48.28 /

-2.34 (-4.62%)

DISH Dish
$39.69 /

-0.335 (-0.84%)

BA Boeing
$245.71 /

+0.64 (+0.26%)

AZN AstraZeneca
$58.62 /

-0.13 (-0.22%)

AMZN Amazon.com
$3,371.43 /

-11.19 (-0.33%)

Hot Stocks
Jounce Therapeutics achieves first milestone in license agreement with Gilead » 08:04
06/15/21
06/15
08:04
06/15/21
08:04
JNCE

Jounce Therapeutics

$6.98 /

-0.07 (-0.99%)

, GILD

Gilead

$68.15 /

+0.09 (+0.13%)

Jounce Therapeutics…

Jounce Therapeutics (JNCE) announced the Food and Drug Administration's clearance of its Investigational New Drug application for JTX-1811, an anti-CCR8 antibody, for which Gilead Sciences (GILD) has exclusive rights to develop and commercialize. The IND clearance triggers a $25M milestone payment to Jounce. Under the terms of the September 2020 agreement, Gilead invested $35M in Jounce's common stock and made an $85M upfront payment to Jounce. Jounce has led the development of JTX-1811 through IND clearance, after which Gilead now has the sole right to develop and commercialize the program. After receiving this $25M milestone payment, Jounce may receive up to an additional $660M in future clinical, regulatory and commercial milestone payments and will also be eligible to receive royalties ranging from high single digit to mid-teens based upon worldwide sales. Any milestone or royalty paid to Jounce is subject to certain reductions as described in the license agreement.

ShowHide Related Items >><<
JNCE Jounce Therapeutics
$6.98 /

-0.07 (-0.99%)

GILD Gilead
$68.15 /

+0.09 (+0.13%)

JNCE Jounce Therapeutics
$6.98 /

-0.07 (-0.99%)

04/12/21 Roth Capital
Jounce reported 'very robust' JTX-8064 analysis, says Roth Capital
03/14/21 Piper Sandler
Jounce Therapeutics initiated with an Overweight at Piper Sandler
02/26/21 H.C. Wainwright
Jounce Therapeutics price target raised to $15 from $11 at H.C. Wainwright
12/04/20 H.C. Wainwright
Jounce Therapeutics assumed with a Buy at H.C. Wainwright
GILD Gilead
$68.15 /

+0.09 (+0.13%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
JNCE Jounce Therapeutics
$6.98 /

-0.07 (-0.99%)

GILD Gilead
$68.15 /

+0.09 (+0.13%)

  • 10
    Mar
GILD Gilead
$68.15 /

+0.09 (+0.13%)

JNCE Jounce Therapeutics
$6.98 /

-0.07 (-0.99%)

GILD Gilead
$68.15 /

+0.09 (+0.13%)

GILD Gilead
$68.15 /

+0.09 (+0.13%)

Recommendations
Eli Lilly price target raised to $260 from $240 at JPMorgan » 07:37
06/15/21
06/15
07:37
06/15/21
07:37
LLY

Eli Lilly

$226.10 /

+1.95 (+0.87%)

, BIIB

Biogen

$406.03 /

+9.57 (+2.41%)

JPMorgan analyst Chris…

JPMorgan analyst Chris Schott raised the firm's price target on Eli Lilly (LLY) to $260 from $240 and keeps an Overweight rating on the shares. The analyst believes Biogen's (BIIB) aducanumab approval increases the probability of success for Lilly's donanemab and likely accelerates development timelines. This is only partially reflected in shares currently, Schott tells investors in a research note. The analyst sees Eli Lilly as the best-positioned growth story in his coverage and the stock remains one of his top picks.

ShowHide Related Items >><<
LLY Eli Lilly
$226.10 /

+1.95 (+0.87%)

BIIB Biogen
$406.03 /

+9.57 (+2.41%)

LLY Eli Lilly
$226.10 /

+1.95 (+0.87%)

06/14/21 Goldman Sachs
Eli Lilly price target raised to $270 from $252 at Goldman Sachs
06/08/21 Baird
Baird upgrades Biogen to Neutral after 'fatal blow' to bear thesis
06/07/21 BofA
BofA upgrades Biogen to Neutral with $400 price target after Aduhelm approved
05/27/21 H.C. Wainwright
H.C. Wainwright bullish on Dicerna as new RNAi candidate enters clinic
BIIB Biogen
$406.03 /

+9.57 (+2.41%)

06/15/21 Citi
Prothena price target raised to $57 from $39 at Citi
06/14/21 Truist
Biogen price target raised to $647 from $458 at Truist
06/14/21 Goldman Sachs
Biogen price target raised to $436 from $246 at Goldman Sachs
LLY Eli Lilly
$226.10 /

+1.95 (+0.87%)

BIIB Biogen
$406.03 /

+9.57 (+2.41%)

LLY Eli Lilly
$226.10 /

+1.95 (+0.87%)

BIIB Biogen
$406.03 /

+9.57 (+2.41%)

LLY Eli Lilly
$226.10 /

+1.95 (+0.87%)

BIIB Biogen
$406.03 /

+9.57 (+2.41%)

LLY Eli Lilly
$226.10 /

+1.95 (+0.87%)

BIIB Biogen
$406.03 /

+9.57 (+2.41%)

Hot Stocks
Eli Lilly announces Emgality, Nurtec ODT head-to-head study » 06:48
06/15/21
06/15
06:48
06/15/21
06:48
LLY

Eli Lilly

$226.10 /

+1.95 (+0.87%)

To advance the science of…

To advance the science of migraine treatment and aid the understanding of calcitonin gene-related peptide, or CGRP, monoclonal antibodies (mAbs) compared to oral CGRP receptor antagonists in the prevention of migraine, Eli Lilly will be conducting a head-to-head study comparing once-monthly injectable Emgality with Nurtec ODT, an orally disintegrating tablet patients take every other day. CGRP is a protein in the brain thought to play a key role in migraine. Emgality binds to this protein, preventing it from attaching to the CGRP receptors, whereas Nurtec ODT blocks the receptor for this protein. The study, which is the first head-to-head clinical trial comparing two medications targeting CGRP, is a multi-site, randomized, double-blind, double-dummy, parallel-group Phase 4 study in patients who meet the International Classification of Headache Disorders, or ICHD, criteria for a diagnosis of episodic migraine with or without aura. There will be two treatment arms: Emgality 120 mg once-monthly injection, with an initial 240 mg loading dose, and Nurtec ODT 75 mg, taken every other day. The study's primary endpoint is 50% reduction in monthly migraine headache days. Enrollment is expected to begin later this year.

ShowHide Related Items >><<
LLY Eli Lilly
$226.10 /

+1.95 (+0.87%)

LLY Eli Lilly
$226.10 /

+1.95 (+0.87%)

06/14/21 Goldman Sachs
Eli Lilly price target raised to $270 from $252 at Goldman Sachs
06/08/21 Baird
Baird upgrades Biogen to Neutral after 'fatal blow' to bear thesis
06/07/21 BofA
BofA upgrades Biogen to Neutral with $400 price target after Aduhelm approved
05/27/21 H.C. Wainwright
H.C. Wainwright bullish on Dicerna as new RNAi candidate enters clinic
LLY Eli Lilly
$226.10 /

+1.95 (+0.87%)

LLY Eli Lilly
$226.10 /

+1.95 (+0.87%)

LLY Eli Lilly
$226.10 /

+1.95 (+0.87%)

LLY Eli Lilly
$226.10 /

+1.95 (+0.87%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.